As such, we hypothesized that a reduction in cholesterol biosynthesis gene expression could be specifically associated with AGS5 and not observed across other AGS subtypes in which cerebrovasculopathy is not reported. This evidence concerns the gene SAMHD1 and Aicardi-Goutieres syndrome.